Nuvaira, Inc.
Nuvaira Inc. is a medical device company dedicated to developing innovative therapies for obstructive lung diseases, including COPD and asthma. Their proprietary dNerva Lung Denervation System addresses airway hyper-responsiveness through a minimally invasive, outpatient bronchoscopic procedure called Targeted Lung Denervation (TLD). The company's mission is to transform the standard of care and significantly improve patient outcomes by reducing exacerbations and preserving lung health.
Industries
Nr. of Employees
medium (51-250)
Nuvaira, Inc.
Minneapolis, Minnesota, United States, North America
Patents
Non-invasive and minimally invasive denervation methods and systems for performing the same
US-12343060-B2
View DetailsSystems, apparatuses, and methods for treating tissue and controlling stenosis
US-12290309-B2
View DetailsMethod and systems for reducing treatment variability and increasing treatment efficacy and durability
US-11896294-B2
View Details
Non-invasive and minimally invasive denervation methods and systems for performing the same
US-12343060-B2
View DetailsSystems, apparatuses, and methods for treating tissue and controlling stenosis
US-12290309-B2
View DetailsMethod and systems for reducing treatment variability and increasing treatment efficacy and durability
US-11896294-B2
View DetailsProducts
Bronchoscopic lung denervation system (catheter-based)
A catheter-delivered bronchoscopic system designed to ablate or disrupt airway/pulmonary nerve signaling in a single outpatient procedure to reduce neural hyperactivity associated with obstructive lung disease.
Bronchoscopic lung denervation system (catheter-based)
A catheter-delivered bronchoscopic system designed to ablate or disrupt airway/pulmonary nerve signaling in a single outpatient procedure to reduce neural hyperactivity associated with obstructive lung disease.
Services
Management and execution of multicenter clinical trials for bronchoscopic device interventions, including site identification, enrollment support, and long-term patient follow-up.
On-site manufacturing process optimization, assembly support, tooling/fixture design input, and cleanroom production practices for catheter-based devices.
Design, validation and maintenance of clinical databases, CRF/eCRF development, edit checks, UAT and user training for clinical study data capture.
Preparation and management of regulatory submissions, interaction with regulatory authorities, and support for coverage/reimbursement engagement.
Management and execution of multicenter clinical trials for bronchoscopic device interventions, including site identification, enrollment support, and long-term patient follow-up.
On-site manufacturing process optimization, assembly support, tooling/fixture design input, and cleanroom production practices for catheter-based devices.
Design, validation and maintenance of clinical databases, CRF/eCRF development, edit checks, UAT and user training for clinical study data capture.
Preparation and management of regulatory submissions, interaction with regulatory authorities, and support for coverage/reimbursement engagement.
Expertise Areas
- Interventional pulmonology procedures (bronchoscopic interventions)
- Clinical trial management for device studies (multicenter RCTs, sham-controlled)
- Medical device R&D and catheter engineering
- Preclinical and translational research (animal and ex vivo models)
Key Technologies
- Bronchoscopic catheter-based neuromodulation
- Catheter design and delivery systems
- Ex vivo and animal model testing
- Randomized double-blind sham-controlled trial methodology